Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,232,602
+$739,694 QoQ
Shares Held
20,794
+0.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#1,286
of 4,153 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $35,051,660 across 8 Drug Manufacturers - General names. ABBV ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,271 | $12,319,346 | |
| 2 | JNJ |
Johnson & Johnson
|
28,172 | $7,154,842 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
20,794 | $5,232,602 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,785 | $3,570,372 | |
| 5 | OGN |
Organon & Co.
|
214,639 | $2,906,212 | |
| 6 | AMGN |
Amgen Inc
|
6,049 | $2,190,463 | |
| 7 | PFE |
Pfizer Inc
|
66,351 | $1,597,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,390 | $80,091 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,232,602 | 20,794 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $4,492,908 | 20,658 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,812,100 | 25,437 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $5,898,249 | 25,474 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $4,601,891 | 24,792 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $5,224,171 | 24,934 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||